Lunit and U.K.’s Leeds Teaching Hospitals NHS Trust said they have kicked off the "world's first" prospective study of artificial intelligence (AI)-powered breast reading in a symptomatic breast clinic environment, utilizing Lunit INSIGHT MMG.This initiative aims to revolutionize breast cancer detec
Genome&Company recently initiated a phase 2 clinical trial for biliary tract cancer by combining MSD's immune checkpoint inhibitor Keytruda (pembrolizumab) with its immuno-oncology candidate GEN-001.Industry insiders are watching with interest what results Genome&Company will achieve as it targets s
Samsung Electronics and AimMed have embarked on an attempt to load a digital therapeutic device (DTx) for insomnia on the wearable device Galaxy Watch.At a workshop organized by the Korean Society of Pharmaceutical Science and Technology last Friday, Jung Kyung-ho, a director at AimMed, said the com
The Korea Disease Control and Prevention Agency (KDCA) said it will commence the first phase of the national immunization program (NIP) for influenza from Wednesday.During the first phase, the KDCA plans to target children under 13, including infants.According to the KDCA, it will vaccinate children
Sanofi Aventis Korea is aiming to revolutionize the treatment landscape for Pompe disease patients with the reimbursement of its novel enzyme replacement therapy, Nexviazyme (ingredient: avalglucosidase alfa-ngpt), from Sep. 1, the company said.Sanofi-Aventis Korea organized a press conference at th
In the wake of revelations that a key ingredient could transform into tumor-inducing kidney cells, Kolon Life Science's osteoarthritis gene therapy, Invossa-K Inj., which had its product license revoked, has been linked to numerous reported cases of tumors in patients after administration.According
Samsung Biologics said it has signed a $242 million contract manufacturing organization (CMO) contract with Swords Laboratories, a subsidiary of Bristol-Myers Squibb (BMS), to manufacture immunotherapy treatment until 2030.Samsung Biologics emphasized that this contract highlights the significant ro
The pet treatment sector, a promising blue ocean market, has lured major Korean pharmaceutical companies since 2021.However, despite optimistic projections and significant investments, as late entrants, Korean pharmaceutical companies are battling to secure a footing amidst established competitors.T
A court has found a psychiatric hospital liable for failing to prevent a patient's suicide attempt due to staff’s negligence, resulting in his death. However, it restricted the level of liability to 50 percent.The Chuncheon District Court recently ruled in partial favor of a medical institution in t
The number of people treated for depression and anxiety disorders among workers in childcare and educational facilities has nearly doubled in the past five years.Rep. Shin Hyun-young of the Democratic Party of Korea analyzed the National Health Insurance Service's data titled "Current Status of Depr
To create future revenue sources, hospitals should move beyond establishing electronic health records (HER) toward developing a “lifelog,” an expert said Thursday.He added that they can turn various medical data research into a business that can generate non-medical revenue.Dr. Kim Jong-yeop, a prof
Korean biotech companies participated in the first summit of CancerX, the first CancerX activity since the organization's launch. However, observers said it would likely take time for the participating companies' R&D activities to get in full swing.The Inaugural CancerX Member Summit was held on Thu
Climate change has had widespread impacts on the planet and its consequences to human health are escalating, presenting challenges for vaccine manufacturers, researchers, and epidemiologists alike. Dr. Adamberage Ruklanthi de Alwis, Deputy Director of the Center for Outbreak Preparedness at Duke-NUS
Moderna announced its collaboration with Korea University Medical Center and Chosun University Industry-Academic Cooperation Foundation on Friday to expand its global public health initiative, mRNA Access, in Korea.The initiative aims to expedite the vaccine development process worldwide using Moder
Daewoong Therapeutics, an affiliate of the Daewoong Group, said on Friday that it received approval from the Ministry of Food and Drug Safety (MFDS) for a phase 1 clinical trial plan for its diabetic retinopathy candidate, DWRX2008. DWRX2008 is a diabetic retinopathy treatment that Daewoong Therapeu
Endocrinology, pediatrics, respiratory medicine, orthopedics, urology, and neurology were among the clinical fields in which Korean hospitals showed strength, with the "Big 5" hospitals occupying higher ranks.The result is from analyzing U.S. magazine Newsweek's "World's Best Specialized Hospitals 2
Microneedle patch technology is being hailed as the solution to conquer the current limitations of vaccines by offering less invasiveness, painlessness, easier administration, and the potential to address cold chain issues.However, it still faces limitations hindering its widespread commercializatio
A local doctor expressed his enthusiasm that the reimbursement of Pfizer Korea's Ngenla (ingredient: Somatropin), a once-weekly growth hormone drug, will enhance compliance among adolescent patients.At a press conference held to mark the reimbursement at the Koreana Hotel in Seoul on Thursday, Profe
Hanmi Pharm has suggested that the company could develop HM15912, its short bowel syndrome treatment candidate developed as a once-monthly dosage form, as a treatment for another rare disease, graft-versus-host disease (GVHD).Hanmi said Thursday that it presented two posters on the research results
The Ministry of Food and Drug Safety (MFDS) said it is pushing for a swift introduction and distribution of a new vaccine developed specifically to counter the XBB 1.5, an Omicron sub-variant, for the 2023-24 winter season.Responding to a request from the Korea Disease Control and Prevention Agency